FDA
-
-
-
-
-
-
-
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
-
-
-
-
-
-
-
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
-
-
-
-
-
-
-
FDA approves ZYCUBO as first Menkes disease treatment
-
-
-
-
-
-
-
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate HighlightsÂ
-
-
-
-
-
-
-
Journey Medical Corporation to Participate in October 2025 Investor Conferences
-
-
-
-
-
-
-
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
-
-
-
-
-
-
-
Journey Medical Corp (DERM) set to join Russell 2000 and 3000
-
328,604 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

